However, a study comparing EPA (2.7 g) and DHA (2.7 g) in individuals with abdominal obesity and low-grade systemic inflammation found lowering of CRP, IL-6, IL-18, and TNF, where DHA was more potent than EPA (91). The gene discussed is CRP; the disease is Abdominal obesity.